Literature DB >> 23742695

Differential expression of mitogen activating protein kinases in periodontitis.

Suncica Travan1, Fei Li, Nisha J D'Silva, Elizabeth H Slate, Keith L Kirkwood.   

Abstract

AIM: Following toll-like receptor (TLR) engagement, lipopolysaccharide (LPS) can stimulate the expression of pro-inflammatory cytokines thus activating the innate immune response. The production of inflammatory cytokines results, in part, from the activation of kinase-induced signalling cascades and transcriptional factors. Of the four distinct classes of mitogen-activated protein kinases (MAPK) described in mammals, p38, c-Jun N-terminal activated kinases (JNK1-3) and extracellular activated kinases (ERK1,2) are the best studied. Previous data have established that p38 MAPK signalling is required for inflammation and bone loss in periodontal disease pre-clinical animal models. MATERIALS &
METHODS: In this study, we obtained healthy and diseased periodontal tissues along with clinical parameters and microbiological parameters. Excised fixed tissues were immunostained with total and phospho-specific antibodies against p38, JNK and ERK kinases.
RESULTS: Intensity scoring from immunostained tissues was correlated with clinical periodontal parameters. Rank correlations with clinical indices were statistically significantly positive (p-value < 0.05) for total p38 (correlations ranging 0.49-0.68), phospho-p38 (range 0.44-0.56), and total ERK (range 0.52-0.59) levels, and correlations with JNK levels also supported association (range 0.42-0.59). Phospho-JNK and phospho-ERK showed no significant positive correlation with clinical parameters of disease.
CONCLUSION: These data strongly implicate p38 MAPK as a major MAPK involved in human periodontal inflammation and severity.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cell signalling; inflammation; mitogen activating protein kinases; periodontitis

Mesh:

Substances:

Year:  2013        PMID: 23742695      PMCID: PMC4091899          DOI: 10.1111/jcpe.12123

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  39 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

2.  Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis.

Authors:  Adelheid Korb; Makiyeh Tohidast-Akrad; Erdal Cetin; Roland Axmann; Josef Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2006-09

3.  Expression of activated transcription factor nuclear factor-kappaB in periodontally diseased tissues.

Authors:  R Ambili; W S Santhi; Prasanthila Janam; K Nandakumar; M Radhakrishna Pillai
Journal:  J Periodontol       Date:  2005-07       Impact factor: 6.993

4.  The Gingival Index, the Plaque Index and the Retention Index Systems.

Authors:  H Löe
Journal:  J Periodontol       Date:  1967 Nov-Dec       Impact factor: 6.993

5.  Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

Authors:  T Nakashima; Y Kobayashi; S Yamasaki; A Kawakami; K Eguchi; H Sasaki; H Sakai
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

6.  Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of benzoyl-DL-arginine-naphthylamide.

Authors:  W J Loesche; W A Bretz; D Kerschensteiner; J Stoll; S S Socransky; P Hujoel; D E Lopatin
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

7.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.

Authors:  G Schett; M Tohidast-Akrad; J S Smolen; B J Schmid; C W Steiner; P Bitzan; P Zenz; K Redlich; Q Xu; G Steiner
Journal:  Arthritis Rheum       Date:  2000-11

Review 8.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

9.  Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.

Authors:  Raj S Mitra; Mitsuo Goto; Julia S Lee; Diana Maldonado; Jeremy M G Taylor; Quintin Pan; Thomas E Carey; Carol R Bradford; Mark E Prince; Kitrina G Cordell; Keith L Kirkwood; Nisha J D'Silva
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

10.  MAPK usage in periodontal disease progression.

Authors:  Qiyan Li; Michael S Valerio; Keith L Kirkwood
Journal:  J Signal Transduct       Date:  2012-01-23
View more
  9 in total

1.  Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2.

Authors:  Michael S Valerio; Bethany A Herbert; Dimitrios S Basilakos; Courtney Browne; Hong Yu; Keith L Kirkwood
Journal:  Cytokine       Date:  2014-09-27       Impact factor: 3.861

2.  A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

Authors:  Muna S Elburki; Carlos Rossa; Morgana R Guimarães-Stabili; Hsi-Ming Lee; Fabiana A Curylofo-Zotti; Francis Johnson; Lorne M Golub
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

3.  Mitogen-Activated Protein Kinase 2 Signaling Shapes Macrophage Plasticity in Aggregatibacter actinomycetemcomitans-Induced Bone Loss.

Authors:  Bethany A Herbert; Heidi M Steinkamp; Matthias Gaestel; Keith L Kirkwood
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

Review 5.  Mini but mighty: microRNAs in the pathobiology of periodontal disease.

Authors:  Moritz Kebschull; Panos N Papapanou
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

6.  A new albumin-depletion strategy improves proteomic research of gingival crevicular fluid from periodontitis patients.

Authors:  Sarah Batschkus; Goekhan Cingoez; Henning Urlaub; Nicolai Miosge; Christian Kirschneck; Philipp Meyer-Marcotty; Christof Lenz
Journal:  Clin Oral Investig       Date:  2017-10-09       Impact factor: 3.573

7.  Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Clin Oral Investig       Date:  2016-06-09       Impact factor: 3.573

Review 8.  Senescent CD4+CD28- T Lymphocytes as a Potential Driver of Th17/Treg Imbalance and Alveolar Bone Resorption during Periodontitis.

Authors:  Luis González-Osuna; Alfredo Sierra-Cristancho; Emilio A Cafferata; Samanta Melgar-Rodríguez; Carolina Rojas; Paola Carvajal; Cristian Cortez; Rolando Vernal
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

9.  Silencing matrix metalloproteinase-13 (Mmp-13) reduces inflammatory bone resorption associated with LPS-induced periodontal disease in vivo.

Authors:  Morgana R Guimaraes-Stabili; Marcell Costa de Medeiros; Danuza Rossi; Angelo Constantino Camilli; Cleslei Fernando Zanelli; Sandro Roberto Valentini; Luis Carlos Spolidorio; Keith Lough Kirkwood; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-11-02       Impact factor: 3.573

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.